150 related articles for article (PubMed ID: 38594660)
1. A cross-sectional study of the association of dental health factors with progression and all-cause mortality in men diagnosed with HPV-associated oropharyngeal cancer.
Dickey BL; Gore LR; Slebos R; Sirak B; Isaacs-Soriano KA; Kennedy K; Otto K; Wadsworth JT; Chung CH; Giuliano AR
BMC Oral Health; 2024 Apr; 24(1):433. PubMed ID: 38594660
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
3. Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States.
Stull C; Bennis SL; Rosser BRS; Wilkerson JM; Zoschke IN; Jiang Z; Nyitray AG; Khariwala SS; Ross MW
J Am Dent Assoc; 2024 Jan; 155(1):26-38.e1. PubMed ID: 37988048
[TBL] [Abstract][Full Text] [Related]
4. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
[TBL] [Abstract][Full Text] [Related]
6. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
9. A Multi-state Evaluation of Oral Health Students' Knowledge of Human Papillomavirus-Related Oropharyngeal Cancer and HPV Vaccination.
Rutkoski H; Tay DL; Dixon BL; Pinzon LM; Mooney R; Winkler JR; Kepka D
J Cancer Educ; 2020 Oct; 35(5):1017-1025. PubMed ID: 31222578
[TBL] [Abstract][Full Text] [Related]
10. Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
Whitmarsh A; Pring M; Thomas SJ; Waylen A; Ness AR; Dudding T; Pawlita M; Brenner N; Waterboer T; Schroeder L
Cancer; 2021 Jul; 127(14):2442-2452. PubMed ID: 33721332
[TBL] [Abstract][Full Text] [Related]
11. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
Lechner M; Vassie C; Kavasogullari C; Jones O; Howard J; Masterson L; Fenton T; Yarbrough W; Waller J; Gilson R
BMJ Open; 2018 Jul; 8(7):e023339. PubMed ID: 30056394
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
[TBL] [Abstract][Full Text] [Related]
15. Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US.
Giuliano AR; Felsher M; Waterboer T; Mirghani H; Mehanna H; Roberts C; Chen YT; Lynam M; Pedrós M; Sanchez E; Sirak B; Surati S; Alemany L; Morais E; Pavón MA
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):783-795. PubMed ID: 37535349
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students.
Farsi NJ; Al Sharif S; Al Qathmi M; Merdad M; Marzouki H; Merdad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3595-3603. PubMed ID: 33369457
[TBL] [Abstract][Full Text] [Related]
17. Dutch dental hygiene students' knowledge of HPV-related oropharyngeal squamous cell carcinoma and HPV vaccination.
Poelman MR; Brand HS; de Jong DG; van den Berg I; Dool R; de Visscher JGAM; Jager DHJ
Int J Dent Hyg; 2024 Feb; 22(1):130-139. PubMed ID: 37691238
[TBL] [Abstract][Full Text] [Related]
18. Discussing HPV and oropharyngeal cancer in dental settings: gender and provider-type matter.
Daley EM; Thompson EL; Beckstead J; Driscoll A; Vamos C; Piepenbrink RP; Desch J; Merrell L; Richardson Cayama MB; Owens H; Lovett SM
Hum Vaccin Immunother; 2021 Dec; 17(12):5454-5459. PubMed ID: 34890526
[TBL] [Abstract][Full Text] [Related]
19. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
